Covid drugs: India, South Africa seek waiver of IPR, patents
New Delhi: Amid the coronavirus pandemic, India and South Africa on Friday proposed a waiver from certain provisions of the global intellectual property rights (IPR) agreement to prevent, contain and treat Covid-19 through unimpeded and timely access to affordable medical products including diagnostic kits, vaccines, medicines, personal protective equipment and ventilators.
Other Foreign Trade Videos
No deal with US without tariff advantage framework: Piyush Goyal at UK-India Week 2026
The UK-India Free Trade Agreement
'This is the right moment...': Piyush Goyal highlights opportunities under India-Canada CEPA
India-Canada aim to conclude CEPA by year-end; triple trade by 2030: Piyush Goyal
China’s 90% Supremacy Model: The chokehold and the way out | ET Titan Talks with Dr Ram Charan
